Hemophilia 360

Integrated Care, Access and Outcomes

18-19 September 2026

Crowne Plaza RDC Hotel Riyadh, KSA

Meet the Faculty

Get to know the experts leading this year's sessions on hemophilia care, access, and evidence.

Dr. Abdullah AlZayed

Hematology Consultant
Qatif Central Hospital, KSA

Dr. Hajer Almudaiheem

Board Member, Saudi Society of

Clinical Pharmacy (SSCP), KSA

Dr. Ibtisam Alharbi

Head of Drug Management

Pharmaceutical Care Department

Ministry of Defense Health Services Riyadh, KSA

Dr. Jude Bin Howaidi

Hematology/Oncology

& BMT Clinical Pharmacist

King Fahad Medical City, KSA

Dr. Abdullah AlZayed

Hematology Consultant
Qatif Central Hospital, KSA

Dr. Hajer Almudaiheem

Dr. Hajer Almudaiheem

Board Member, Saudi Society of

Clinical Pharmacy (SSCP), KSA

Board Member, Saudi Society of

Clinical Pharmacy (SSCP), KSA

Dr. Ibtisam Alharbi

Head of Drug Management

Pharmaceutical Care Department

Ministry of Defense Health Services Riyadh, KSA

Dr. Jude Bin Howaidi

Hematology/Oncology

& BMT Clinical Pharmacist

King Fahad Medical City, KSA

Dr. Laila Abu Esba

Clinical Pharmacist In Charge of the Drug Information

& Poison Center

Ministry of National Guard Health Affairs, KSA

Dr. Mashael Alfaifi

Director of Research & Innovation

King Saud Medical City, KSA

Dr. Mohamed Ahmed

Manager of Therapy Evidence Based Evaluation Formulary Management Department (FMD)

King Faisal Specialist Hospital, KSA

Dr. Mohsen Alzahrani

Assistant Professor, College of Medicine

University of King Saud Bin Abdulaziz for Health Sciences
Hematology and Stem Cell Transplant Consultant

Section Head Adult Stem Cell Transplant & Cellular Therapy

Department of Oncology, King Abdulaziz Medical City

Ministry of National Guard Health Affairs, KSA

Dr. Laila Abu Esba

Clinical Pharmacist In Charge of the Drug Information & Poison Center

Ministry of National Guard Health Affairs, KSA

Dr. Mashael Alfaifi

Director of Research & Innovation

King Saud Medical City, KSA

Dr. Mohamed Ahmed

Manager of Therapy Evidence Based Evaluation Formulary Management Department (FMD)

King Faisal Specialist Hospital, KSA

Dr. Mohsen Alzahrani

Assistant Professor

College of Medicine

University of King Saud Bin Abdulaziz for Health Sciences
Hematology and Stem Cell Transplant Consultant

Section Head Adult Stem Cell Transplant & Cellular Therapy

Department of Oncology, King Abdulaziz Medical City

Ministry of National Guard Health Affairs, KSA

Dr. Nada Alagil

Senior Medical Advisor

Council of Health Insurance (CHI), Riyadh, KSA

Dr. Rawan Almasuood

Senior Specialist – Health Economics

HTA & Drug Policy, KSA

Dr. Wejdan Aburas

PharmD, BCPS

Senior Clinical Benefit Assessment Specialist

Center for National Health Insurance (CNHI), KSA

Dr. Nada Alagil

Senior Medical Advisor

Council of Health Insurance (CHI), Riyadh, KSA

Dr. Rawan Almasuood

Senior Specialist

– Health Economics

HTA & Drug Policy, KSA

Dr. Wejdan Aburas

PharmD, BCPS

Senior Clinical Benefit Assessment Specialist

Center for National Health Insurance (CNHI), KSA

Dr. Yazeed Alruthia

Vice President, Saudi Society of Pharmacoeconomics & Outcomes Research

Dr. Yazeed Alruthia

Vice President, Saudi Society of Pharmacoeconomics & Outcomes Research

VENUE

Crowne Plaza RDC Hotel, Riyadh KSA

Wadi Al Muaydin, Street, Unit 4, Imam Saud Ibn Abdul Aziz Road, Riyadh 12382, Saudi Arabia

QUICK LINKS

FOLLOW US

Copyright Hemophilia 360 Summit 2026. All Rights Reserved.